No credit card. No commitment.
5000+ G2 reviews
OncoDNA - BioSequence
Research
Founded in 2012
Valencia, Valencian CommunityOncoDNA - BioSequence
ResearchFounded in 2012Valencia, Valencian Community
EmployeesOncoDNA - BioSequence's financial review
Employees
5
OncoDNA - BioSequence information
BioSequence ofrece servicios de ayuda para el diagnóstico oncológico personalizado. Utilizamos tecnologías genómicas como la ultrasecuenciación y los microarrays para detectar mutaciones en genes relacionados con la mayor parte de los cánceres y tratamientos oncológicos conocidos. Trabajamos en colaboración con el Baylor College of Medicine's Cancer Genetics Laboratory (CGL) para ofrecer servicios...
BioSequence ofrece servicios de ayuda para el diagnóstico oncológico personalizado. Utilizamos tecnologías genómicas como la ultrasecuenciación y los microarrays para detectar mutaciones en genes relacionados con la mayor parte de los cánceres y tratamientos oncológicos conocidos. Trabajamos en colaboración con el Baylor College of Medicine's Cancer Genetics Laboratory (CGL) para ofrecer servicios de máxima calidad y rigor científico.
OncoDNA - BioSequence industries
Ayuda al diagnostico oncologico personalizado
Ultrasecuenciacion genomica
Microarrays
Research
OncoDNA - BioSequence's financial review
Employees
5
Employee Metrics
Technologies
Email Providers
Online Video Platforms
Fonts
Tag Management
Captcha
OncoDNA - BioSequence's Competitors
Notable Alumni
Employees
Head of Global Distribution
PhD in Biotechnology. Researcher & Data Scientist. Project Coordinator & Scientific Support
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
